urea and dmp 450

urea has been researched along with dmp 450 in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (71.43)18.2507
2000's3 (21.43)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bacheler, LT; De Lucca, GV; Jacobs, K; Jadhav, PK; Kaltenbach, RF; Klabe, RM; Meyer, DT; Nugiel, DA; Patel, M; Rayner, MM; Seitz, SP; Smyser, TE; Worley, T1
Grubb, MF; Krauthauser, CL; Robinson, CA; Shum, L; White, SJ1
Aldrich, PE; Bacheler, LT; Chang, CH; Erickson-Viitanen, S; Eyermann, CJ; Garber, S; Grubb, M; Hodge, CN; Jackson, DA; Jadhav, PK; Korant, B; Lam, PY; Maurin, MB; Meek, JL; Otto, MJ; Rayner, MM; Reid, C; Sharpe, TR; Shum, L; Winslow, DL1
Ala, PJ; Chang, CH; DeLoskey, RJ; Duke, JL; Hodge, CN; Huston, EE; Klabe, RM; Korant, BD; Lam, PY; McCabe, DD; Rizzo, CJ1
Cordova, B; Jackson, DA; Rayner, MM1
Ala, PJ; Chang, CH; DeLoskey, RJ; Duke, JL; Eyermann, CJ; Hodge, CN; Huston, EE; Jadhav, PK; Lam, PY; Lewandowski, FA; McCabe, DD; Schadt, MC; Weber, PC1
Bacheler, LT; Cordova, B; De Lucca, GV; Erickson-Viitanen, S; Garber, S; Kim, UT; Klabe, RM; Ko, SS; Lam, GN; Liang, J; Logue, KA; Trainor, GL; Wright, MR1
Aungst, BJ; De Lucca, GV; Erickson-Viitanen, S; Jadhav, PK; Lam, PY; Waltermire, RE1
Bacheler, LT; Cordova, BC; Erickson-Viitanen, S; Klabe, RM; Patel, M; Rayner, MM; Seitz, SP1
Maurin, MB; Vickery, RD1
Aungst, BJ; Bulgarelli, JP; Nguyen, NH; Oates-Lenz, K1
Hylton, KG; Main, AD; McElwee-White, L1
Sussman, F; Vilar, S; Villaverde, MC1
Li, P; Wang, H; Wang, S; Yan, H1

Reviews

1 review(s) available for urea and dmp 450

ArticleYear
De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule.
    Pharmaceutical biotechnology, 1998, Volume: 11

    Topics: Animals; Azepines; Binding Sites; Drug Design; HIV Protease; HIV Protease Inhibitors; Humans; Molecular Conformation; Urea

1998

Other Studies

13 other study(ies) available for urea and dmp 450

ArticleYear
Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors.
    Journal of medicinal chemistry, 1996, May-24, Volume: 39, Issue:11

    Topics: Azepines; Binding Sites; Cell Line; Cell Survival; Crystallography, X-Ray; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Urea

1996
Determination of a HIV protease inhibitor (DMP 450) in animal and human plasma by solid-phase extraction and high-performance liquid chromatography.
    Journal of chromatography. B, Biomedical applications, 1996, Apr-12, Volume: 678, Issue:2

    Topics: Acetonitriles; Animals; Azepines; Chromatography, High Pressure Liquid; Dogs; Haplorhini; HIV Protease Inhibitors; Humans; Hydrogen-Ion Concentration; Methanol; Pan troglodytes; Phosphates; Potassium Compounds; Rats; Sensitivity and Specificity; Urea

1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450.
    Chemistry & biology, 1996, Volume: 3, Issue:4

    Topics: Administration, Oral; Animals; Azepines; Crystallography, X-Ray; Drug Resistance, Microbial; HIV Protease Inhibitors; HIV-1; Humans; Infusions, Intravenous; Mice; Microscopy, Electron; Solubility; Urea; Virus Replication

1996
Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors.
    Biochemistry, 1997, Feb-18, Volume: 36, Issue:7

    Topics: Azepines; Binding Sites; Crystallography, X-Ray; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; Kinetics; Molecular Sequence Data; Mutagenesis, Insertional; Protein Conformation; Structure-Activity Relationship; Urea

1997
Population dynamics studies of wild-type and drug-resistant mutant HIV in mixed infections.
    Virology, 1997, Sep-15, Volume: 236, Issue:1

    Topics: Alkynes; Azepines; Benzoxazines; Cyclopropanes; Drug Resistance, Microbial; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Microbial Sensitivity Tests; Oxazines; Population Dynamics; Reverse Transcriptase Inhibitors; Time Factors; Urea; Viral Plaque Assay

1997
Molecular recognition of cyclic urea HIV-1 protease inhibitors.
    The Journal of biological chemistry, 1998, May-15, Volume: 273, Issue:20

    Topics: Anti-HIV Agents; Azepines; HIV Protease; HIV Protease Inhibitors; HIV-1; Hydrogen Bonding; Molecular Conformation; Urea

1998
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.
    Journal of medicinal chemistry, 1998, Jun-18, Volume: 41, Issue:13

    Topics: Administration, Oral; Animals; Anti-HIV Agents; Azepines; Biological Availability; Cell Line; Chromatography, High Pressure Liquid; Dogs; Drug Design; Drug Resistance, Microbial; HIV Protease Inhibitors; HIV-1; Indazoles; Mutation; Ritonavir; RNA, Viral; Structure-Activity Relationship; Transcription, Genetic; Urea

1998
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues.
    Bioorganic & medicinal chemistry letters, 1998, Apr-07, Volume: 8, Issue:7

    Topics: Antiviral Agents; Azepines; HIV; HIV Protease; HIV Protease Inhibitors; Indicators and Reagents; Kinetics; Molecular Structure; Structure-Activity Relationship; Urea

1998
Utility of microcalorimetry in the characterization of the browning reaction.
    Journal of pharmaceutical and biomedical analysis, 1999, Volume: 20, Issue:1-2

    Topics: Azepines; Calorimetry; Chromatography, High Pressure Liquid; HIV Protease Inhibitors; Hot Temperature; Lactose; Temperature; Urea

1999
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds.
    Pharmaceutical research, 2000, Volume: 17, Issue:10

    Topics: Acetamides; Albumins; Azepines; Caco-2 Cells; Carbamates; Cell Membrane Permeability; Furans; HIV Protease Inhibitors; Humans; Indinavir; Intestinal Absorption; Nelfinavir; Ritonavir; Solvents; Structure-Activity Relationship; Sulfonamides; Urea

2000
Catalytic carbonylation of functionalized diamines: application to the core structure of DMP 323 and DMP 450.
    The Journal of organic chemistry, 2003, Feb-21, Volume: 68, Issue:4

    Topics: Azepines; Carbon Compounds, Inorganic; Catalysis; Diamines; HIV Protease Inhibitors; Molecular Structure; Tungsten; Urea

2003
Inhibitor docking screened by the modified SAFE_p scoring function: application to cyclic urea HIV-1 PR inhibitors.
    Journal of computational chemistry, 2007, Volume: 28, Issue:13

    Topics: Algorithms; Amino Acids; Azepines; Binding Sites; Computer Simulation; HIV Protease; HIV Protease Inhibitors; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Structure; Protein Binding; Static Electricity; Thermodynamics; Urea

2007
Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C
    Biological & pharmaceutical bulletin, 2019, Volume: 42, Issue:2

    Topics: Azepines; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Urea; Urease

2019